158 related articles for article (PubMed ID: 1331590)
21. Stimulant effects of 5-hydroxytryptamine on guinea pig stomach preparations in vitro.
Buchheit KH; Buhl T
Eur J Pharmacol; 1994 Sep; 262(1-2):91-7. PubMed ID: 7813582
[TBL] [Abstract][Full Text] [Related]
22. [3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.
Bonhaus DW; Loury DN; Jakeman LB; To Z; DeSouza A; Eglen RM; Wong EH
J Pharmacol Exp Ther; 1993 Nov; 267(2):961-70. PubMed ID: 8246171
[TBL] [Abstract][Full Text] [Related]
23. Increased gut cholinergic activity and antagonism of 5-hydroxytryptamine M-receptors by BRL 24924: potential clinical importance of BRL 24924.
Sanger GJ
Br J Pharmacol; 1987 May; 91(1):77-87. PubMed ID: 3594084
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological characterization of 5-hydroxytryptamine3 receptors in murine brain and ileum using the novel radioligand [3H]RS-42358-197: evidence for receptor heterogeneity.
Bonhaus DW; Wong EH; Stefanich E; Kunysz EA; Eglen RM
J Neurochem; 1993 Nov; 61(5):1927-32. PubMed ID: 8229003
[TBL] [Abstract][Full Text] [Related]
25. The interaction of antidepressant drugs with central and peripheral (enteric) 5-HT3 and 5-HT4 receptors.
Lucchelli A; Santagostino-Barbone MG; Barbieri A; Candura SM; Tonini M
Br J Pharmacol; 1995 Mar; 114(5):1017-25. PubMed ID: 7780635
[TBL] [Abstract][Full Text] [Related]
26. The effects of SB 204070, a highly potent and selective 5-HT4 receptor antagonist, on guinea-pig distal colon.
Wardle KA; Ellis ES; Baxter GS; Kennett GA; Gaster LM; Sanger GJ
Br J Pharmacol; 1994 Jul; 112(3):789-94. PubMed ID: 7921604
[TBL] [Abstract][Full Text] [Related]
27. DAU 6285: a novel antagonist at the putative 5-HT4 receptor.
Schiavone A; Giraldo E; Giudici L; Turconi M; Sagrada A
Life Sci; 1992; 51(8):583-92. PubMed ID: 1640809
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological analyses of endo-6-methoxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-2,3-dihydro-2-oxo-1 H- benzimidazole-1-carboxylate hydrochloride (DAU 6285) at the 5-hydroxytryptamine4 receptor in the tunica muscularis mucosae of rat esophagus and ileum of guinea pig: role of endogenous 5-hydroxytryptamine.
Waikar MV; Hegde SS; Ford AP; Clarke DE
J Pharmacol Exp Ther; 1993 Feb; 264(2):654-61. PubMed ID: 8437113
[TBL] [Abstract][Full Text] [Related]
29. An examination of the 5-HT3 receptor mediating contraction and evoked [3H]-acetylcholine release in the guinea-pig ileum.
Fox A; Morton IK
Br J Pharmacol; 1990 Nov; 101(3):553-8. PubMed ID: 2150179
[TBL] [Abstract][Full Text] [Related]
30. 5-hydroxytryptamine4 receptor agonists facilitate cholinergic transmission in the circular muscle of guinea pig ileum: antagonism by tropisetron and DAU 6285.
Tonini M; Candura SM; Onori L; Coccini T; Manzo L; Rizzi CA
Life Sci; 1992; 50(21):PL173-8. PubMed ID: 1315899
[TBL] [Abstract][Full Text] [Related]
31. SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo.
Bachy A; Héaulme M; Giudice A; Michaud JC; Lefevre IA; Souilhac J; Manara L; Emerit MB; Gozlan H; Hamon M
Eur J Pharmacol; 1993 Jun; 237(2-3):299-309. PubMed ID: 7689975
[TBL] [Abstract][Full Text] [Related]
32. RS 42358-197, a novel and potent 5-HT3 receptor antagonist, in vitro and in vivo.
Eglen RM; Lee CH; Smith WL; Johnson LG; Whiting RL; Hegde SS
J Pharmacol Exp Ther; 1993 Aug; 266(2):535-43. PubMed ID: 8355189
[TBL] [Abstract][Full Text] [Related]
33. Identification of SK-951, a novel benzofuran derivative, as an agonist to 5-HT4 receptors.
Takeda M; Tsukamoto K; Mizutani Y; Suzuki T; Taniyama K
Jpn J Pharmacol; 1999 Feb; 79(2):203-12. PubMed ID: 10202856
[TBL] [Abstract][Full Text] [Related]
34. Selective 5-hydroxytryptamine3 (5-HT3) receptor blocking activity of KB-R6933, a novel benzimidazole derivative.
Ozaki A; Fujishima Y; Sukamoto T
Jpn J Pharmacol; 1999 May; 80(1):25-32. PubMed ID: 10446753
[TBL] [Abstract][Full Text] [Related]
35. Effects of DAU 6215, a novel 5-hydroxytryptamine3 (5-HT3) antagonist on electrophysiological properties of the rat hippocampus.
Passani MB; Pugliese AM; Azzurrini M; Corradetti R
Br J Pharmacol; 1994 Jun; 112(2):695-703. PubMed ID: 8075890
[TBL] [Abstract][Full Text] [Related]
36. Benzimidazolone derivatives: a new class of 5-hydroxytryptamine4 receptor agonists with prokinetic and acetylcholine releasing properties in the guinea pig ileum.
Rizzi CA; Coccini T; Onori L; Manzo L; Tonini M
J Pharmacol Exp Ther; 1992 May; 261(2):412-9. PubMed ID: 1578356
[TBL] [Abstract][Full Text] [Related]
37. The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist.
Yoshikawa T; Yoshida N; Oka M
Br J Pharmacol; 2001 May; 133(2):253-60. PubMed ID: 11350861
[TBL] [Abstract][Full Text] [Related]
38. LY277359 maleate: a potent and selective 5-HT3 receptor antagonist without gastroprokinetic activity.
Cohen ML; Bloomquist W; Gidda JS; Lacefield W
J Pharmacol Exp Ther; 1990 Jul; 254(1):350-5. PubMed ID: 2366187
[TBL] [Abstract][Full Text] [Related]
39. SDZ 205-557, a selective, surmountable antagonist for 5-HT4 receptors in the isolated guinea pig ileum.
Buchheit KH; Gamse R; Pfannkuche HJ
Naunyn Schmiedebergs Arch Pharmacol; 1992 Apr; 345(4):387-93. PubMed ID: 1620241
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological properties of quinoxaline derivatives as a new class of 5-HT3 receptor antagonists.
Lasheras B; Berjón A; Montañés R; Roca J; Romero G; Ramírez MJ; Del Río J
Arzneimittelforschung; 1996 Apr; 46(4):401-6. PubMed ID: 8740088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
